4.3700
-0.1100
(-2.46%)
At close: January 10 at 4:00:02 PM EST
4.3700
0.00
(0.00%)
After hours: January 10 at 4:01:37 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 3 | 5 | 6 |
| Avg. Estimate | -0.29 | -0.27 | -0.14 | -1.08 |
| Low Estimate | -0.34 | -0.3 | -0.24 | -1.51 |
| High Estimate | -0.23 | -0.22 | -0.08 | -0.81 |
| Year Ago EPS | -0.4 | -0.43 | -1.59 | -0.14 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 3 | 6 | 5 |
| Avg. Estimate | -- | -- | 80.47M | -- |
| Low Estimate | -- | -- | 80M | -- |
| High Estimate | -- | -- | 82.83M | -- |
| Year Ago Sales | 871k | -- | 2.81M | 80.47M |
| Sales Growth (year/est) | -100.00% | 0.00% | 2,768.88% | -100.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.43 | -0.44 | 0.06 | -0.4 |
| EPS Actual | -0.4 | -0.43 | 0.87 | -0.46 |
| Difference | 0.03 | 0.01 | 0.81 | -0.07 |
| Surprise % | 7.90% | 1.63% | 1,250.09% | -16.55% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.29 | -0.27 | -0.14 | -1.08 |
| 7 Days Ago | -0.29 | -0.26 | -0.15 | -1.05 |
| 30 Days Ago | -0.29 | -0.26 | -0.15 | -1.06 |
| 60 Days Ago | -0.31 | -0.27 | -0.24 | -1.02 |
| 90 Days Ago | -0.31 | -0.27 | -0.24 | -1.02 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 4 | 2 | 5 | 3 |
| Up Last 30 Days | 4 | 2 | 5 | 3 |
| Down Last 7 Days | 2 | -- | 1 | 4 |
| Down Last 30 Days | 2 | -- | 1 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FULC | 27.92% | 37.21% | 90.94% | -650.00% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 11/14/2024 |
| Downgrade | RBC Capital: Outperform to Sector Perform | 9/13/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 9/13/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 9/12/2024 |
| Downgrade | B of A Securities: Neutral to Underperform | 9/12/2024 |
Related Tickers
ANRO Alto Neuroscience, Inc.
4.3500
-1.36%
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
ZNTL Zentalis Pharmaceuticals, Inc.
2.7500
-1.08%
DSGN Design Therapeutics, Inc.
4.5200
-10.94%
PHVS Pharvaris N.V.
17.80
-3.99%
RZLT Rezolute, Inc.
4.9000
-5.95%
MGTX MeiraGTx Holdings plc
6.20
-2.36%
PTGX Protagonist Therapeutics, Inc.
36.61
-2.68%
DYN Dyne Therapeutics, Inc.
15.87
-31.15%
ANNX Annexon, Inc.
4.8300
-0.21%